Evidence map›Paper›PMID 29159468›Full record

ArticleDiabetologia2018

HbA

Roderick C Slieker, Amber A W A van der Heijden, Nienke van Leeuwen, Hailiang Mei, Giel Nijpels, Joline W J Beulens, Leen M 't Hart

Abstract read
In one paragraph

Article in Diabetologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Roderick C SliekerDepartment of Molecular Cell Biology, Leiden University Medical Center, Postal Box 9600, 2300 RC, Leiden, the Netherlands.
Amber A W A van der HeijdenDepartment of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands.
Nienke van LeeuwenDepartment of Molecular Cell Biology, Leiden University Medical Center, Postal Box 9600, 2300 RC, Leiden, the Netherlands.
Hailiang MeiSequencing Analysis Support Core, Leiden University Medical Center, Leiden, the Netherlands.
Giel NijpelsDepartment of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands.
Joline W J BeulensDepartment of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands.
Leen M 't HartDepartment of Molecular Cell Biology, Leiden University Medical Center, Postal Box 9600, 2300 RC, Leiden, the Netherlands. lmthart@lumc.nl.

Funding

BBMRI CP2013-69ZonMw 113102006
6 · The paper itself

Abstract

aims/hypothesisIndividuals with type 2 diabetes are heterogeneous in their glycaemic control as tracked by blood HbA

methodsHbA

resultsAt baseline, 220 genes (1.4%) were associated with baseline HbA CONCLUSIONS/

interpretationHbA

Indexed as

AdultBlood GlucoseCell CycleCell DivisionDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansHypoglycemic AgentsMaleMiddle AgedBlood GlucoseGlycated HemoglobinHypoglycemic AgentsBloodGene expressionGlucose levelsHbA1cImmune responseRNA sequencing

Identifiers

PMID29159468
PMCPMC6448931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.